标题
Targeting protein kinase-b3 (akt3) signaling in melanoma
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 21, Issue 3, Pages 273-290
出版商
Informa UK Limited
发表日期
2017-01-09
DOI
10.1080/14728222.2017.1279147
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- UVA-Irradiation Induces Melanoma Invasion via the Enhanced Warburg Effect
- (2016) York Kamenisch et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1
- (2015) Pei Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
- (2015) Gry Irene Magnussen et al. BMC CANCER
- Anti-programmed cell death protein-1/ligand-1 therapy in different cancers
- (2015) B Homet Moreno et al. BRITISH JOURNAL OF CANCER
- Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis
- (2015) Guang-Wei Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ
- (2015) Keiji Tanese et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
- (2015) Jean Jacques Grob et al. LANCET ONCOLOGY
- Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway
- (2015) G. R. Kardos et al. MOLECULAR CANCER RESEARCH
- BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model
- (2015) Daniele Perna et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
- (2015) Min-Sik Lee et al. Nature Communications
- Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells
- (2015) Heather G. Hambright et al. Oncotarget
- The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis
- (2015) Jade Peres et al. Oncotarget
- AKT1 Activation Promotes Development of Melanoma Metastases
- (2015) Joseph H. Cho et al. Cell Reports
- Nivolumab in melanoma: latest evidence and clinical potential
- (2015) Douglas B. Johnson et al. Therapeutic Advances in Medical Oncology
- Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
- (2015) Zeynep Eroglu et al. Therapeutic Advances in Medical Oncology
- Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
- (2015) Melanie Sweetlove et al. Frontiers in Oncology
- Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
- (2015) Jennifer M. Atkinson et al. PLoS One
- GSK-3 as potential target for therapeutic intervention in cancer
- (2015) James A. McCubrey et al. Oncotarget
- Tumour Suppressive Effects of WEE1 Gene Silencing in Breast Cancer Cells
- (2014) Naghmeh Ghiasi et al. Asian Pacific Journal of Cancer Prevention
- PI3K/Akt-mediated regulation of p53 in cancer
- (2014) Aswin G. Abraham et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Involvement of miR-605 and miR-34a in the DNA Damage Response Promotes Apoptosis Induction
- (2014) Chun-Hong Zhou et al. BIOPHYSICAL JOURNAL
- Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma
- (2014) Camila S Oliveira et al. BMC CANCER
- Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program
- (2014) Paolo Antonio Ascierto et al. CANCER INVESTIGATION
- Sestrin2 Protein Positively Regulates AKT Enzyme Signaling and Survival in Human Squamous Cell Carcinoma and Melanoma Cells
- (2014) Baozhong Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways
- (2014) Shi-Yun Cui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients WithBRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor
- (2014) Douglas B. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the PI3K/AKT pathway by microRNA-22 results in CLL B-cell proliferation
- (2014) F Palacios et al. LEUKEMIA
- Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma
- (2014) Amanda Lassen et al. Molecular Cancer
- Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA
- (2014) K Hayashi et al. ONCOGENE
- Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway
- (2014) J J Havel et al. ONCOGENE
- Adaptive resistance to RAF inhibitors in melanoma
- (2014) Curtis H. Kugel et al. Pigment Cell & Melanoma Research
- AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake
- (2014) Ramachandran Rashmi et al. PLoS One
- Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor
- (2014) Melissa Dumble et al. PLoS One
- The pentose phosphate pathway and cancer
- (2014) Krushna C. Patra et al. TRENDS IN BIOCHEMICAL SCIENCES
- Mir-34: A New Weapon Against Cancer?
- (2014) Gabriella Misso et al. Molecular Therapy-Nucleic Acids
- Targeting PI3K/Akt/mTOR Signaling in Cancer
- (2014) Camillo Porta et al. Frontiers in Oncology
- Identification of Aurora Kinase B and Wee1-Like Protein Kinase as Downstream Targets of V600EB-RAF in Melanoma
- (2013) Arati Sharma et al. AMERICAN JOURNAL OF PATHOLOGY
- WEE1 inhibition and genomic instability in cancer
- (2013) Lianne E.M. Vriend et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion
- (2013) S Khosravi et al. BRITISH JOURNAL OF CANCER
- Wee1 kinase as a target for cancer therapy
- (2013) Khanh Do et al. CELL CYCLE
- AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion
- (2013) Seung-Keun Hong et al. EXPERIMENTAL CELL RESEARCH
- Akt-dependent Activation of the Heart 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase (PFKFB2) Isoenzyme by Amino Acids
- (2013) Laura Novellasdemunt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Melanoma-associated mutations in protein phosphatase 6 cause chromosome instability and DNA damage owing to dysregulated Aurora-A
- (2013) D. Hammond et al. JOURNAL OF CELL SCIENCE
- PKB/Akt-Dependent Regulation of Cell Motility
- (2013) G. Xue et al. JNCI-Journal of the National Cancer Institute
- GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug
- (2013) S-H Kao et al. ONCOGENE
- Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma
- (2013) SubbaRao V. Madhunapantula et al. Pigment Cell & Melanoma Research
- Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors
- (2013) Jaehyuk Choi et al. Pigment Cell & Melanoma Research
- Targeting protein–protein interactions as an anticancer strategy
- (2013) Andrei A. Ivanov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition
- (2013) H. Shi et al. Cancer Discovery
- Complex roles of filamin-A mediated cytoskeleton network in cancer progression
- (2013) Jingyin Yue et al. Cell and Bioscience
- Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells
- (2013) Lakshmipathi Vadlakonda et al. Frontiers in Oncology
- Role of PRAS40 in Akt and mTOR signaling in health and disease
- (2012) Claudia Wiza et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The emerging multiple roles of nuclear Akt
- (2012) Alberto M. Martelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Akt signaling pathway
- (2012) SubbaRao V. Madhunapantula et al. CANCER BIOLOGY & THERAPY
- Selenium-containing histone deacetylase inhibitors for melanoma management
- (2012) Raghavendra Gowda et al. CANCER BIOLOGY & THERAPY
- The Role of the PI3K-AKT Pathway in Melanoma
- (2012) Michael A. Davies CANCER JOURNAL
- PRAS40 Is a Functionally Critical Target for EWS Repression in Ewing Sarcoma
- (2012) L. Huang et al. CANCER RESEARCH
- Nexrutine(R) inhibits tumorigenesis in mouse skin and induces apoptotic cell death in human squamous carcinoma A431 and human melanoma A375 cells
- (2012) R. Kumar et al. CARCINOGENESIS
- Sestrins Activate Nrf2 by Promoting p62-Dependent Autophagic Degradation of Keap1 and Prevent Oxidative Liver Damage
- (2012) Soo Han Bae et al. Cell Metabolism
- The Akt-associated microRNAs
- (2012) Min Xu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Feedforward and feedback regulation of the MAPK and PI3K oscillatory circuit in breast cancer
- (2012) Huizhong Hu et al. CELLULAR SIGNALLING
- Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
- (2012) L. C. W. Vredeveld et al. GENES & DEVELOPMENT
- GSK3β Inhibition Blocks Melanoma Cell/Host Interactions by Downregulating N-Cadherin Expression and Decreasing FAK Phosphorylation
- (2012) Jobin K. John et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use
- (2012) Paolo A Ascierto et al. Journal of Translational Medicine
- GSK-3 Promotes Cell Survival, Growth, and PAX3 Levels in Human Melanoma Cells
- (2012) J. D. Kubic et al. MOLECULAR CANCER RESEARCH
- Simultaneous Targeting of COX-2 and AKT Using Selenocoxib-1-GSH to Inhibit Melanoma
- (2012) R. Gowda et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma
- (2012) A Bhattacharya et al. ONCOGENE
- Targeting sphingosine kinase-1 to inhibit melanoma
- (2012) SubbaRao V. Madhunapantula et al. Pigment Cell & Melanoma Research
- Role of MicroRNA-182 in Posterior Uveal Melanoma: Regulation of Tumor Development through MITF, BCL2 and Cyclin D2
- (2012) Dongsheng Yan et al. PLoS One
- BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines
- (2012) Brenden Chen et al. PLoS One
- Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance
- (2012) Hubing Shi et al. Nature Communications
- MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN
- (2011) Guangyun Tan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PI3K-AKT-FoxO axis in cancer and aging
- (2011) Guri Tzivion et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
- (2011) Guri Tzivion et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Resistance to BRAF Inhibitors: Unraveling Mechanisms and Future Treatment Options
- (2011) J. Villanueva et al. CANCER RESEARCH
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- (2011) M. Garofalo et al. CURRENT MOLECULAR MEDICINE
- GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
- (2011) Hagit Eldar-Finkelman et al. Frontiers in Molecular Neuroscience
- Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development
- (2010) Sung Jin Huh et al. AMERICAN JOURNAL OF PATHOLOGY
- Stress-Responsive Sestrins Link p53 with Redox Regulation and Mammalian Target of Rapamycin Signaling
- (2010) Andrei V. Budanov ANTIOXIDANTS & REDOX SIGNALING
- Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail
- (2010) Gajanan S. Inamdar et al. BIOCHEMICAL PHARMACOLOGY
- Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and 5 Integrin Upregulation
- (2010) J. A. McKenzie et al. CANCER RESEARCH
- Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma
- (2010) S. A. Aziz et al. CLINICAL CANCER RESEARCH
- Vertical Inhibition of the mTORC1/mTORC2/PI3K Pathway Shows Synergistic Effects against Melanoma In Vitro and In Vivo
- (2010) Johannes Werzowa et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Protein Tyrosine Kinase 6 Directly Phosphorylates AKT and Promotes AKT Activation in Response to Epidermal Growth Factor
- (2010) Y. Zheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis
- (2010) C Nogueira et al. ONCOGENE
- Vimentin is a novel AKT1 target mediating motility and invasion
- (2010) Q-S Zhu et al. ONCOGENE
- PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas)
- (2010) Sandra Medic et al. PLoS One
- The dual kinase complex FAK-Src as a promising therapeutic target in cancer
- (2010) Victoria Bolós OncoTargets and Therapy
- Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis
- (2009) Rania Harfouche et al. ANGIOGENESIS
- A complex interplay between Akt, TSC2 and the two mTOR complexes: Figure 1
- (2009) Jingxiang Huang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
- (2009) Nathalie Dhomen et al. CANCER CELL
- Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma
- (2009) S. A. Aziz et al. CLINICAL CANCER RESEARCH
- Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt
- (2009) Dong Bai et al. INTERNATIONAL JOURNAL OF CANCER
- Macrophage Inhibitory Cytokine-1: A New Player in Melanoma Development
- (2009) Toshiharu Yamashita et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB
- (2009) Hui-Kuan Lin et al. NATURE CELL BIOLOGY
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
- (2009) Seung-Shick Shin et al. Pigment Cell & Melanoma Research
- The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma
- (2009) SubbaRao V. Madhunapantula et al. Pigment Cell & Melanoma Research
- MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells
- (2009) D. Iliopoulos et al. Science Signaling
- Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
- (2009) Morris E Feldman et al. PLOS BIOLOGY
- PRAS40: Target or modulator of mTORC1 signalling and insulin action?
- (2009) Emmani B.M. Nascimento et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- PPARβ/δ agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-κB signals
- (2008) ShouWei Han et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias
- (2008) M S Kim et al. BRITISH JOURNAL OF CANCER
- A novel AKT3 mutation in melanoma tumours and cell lines
- (2008) M A Davies et al. BRITISH JOURNAL OF CANCER
- Targeting V600EB-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development
- (2008) M. A. Tran et al. CANCER RESEARCH
- Is B-Raf a Good Therapeutic Target for Melanoma and Other Malignancies?
- (2008) S. V. Madhunapantula et al. CANCER RESEARCH
- Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development
- (2008) M. Cheung et al. CANCER RESEARCH
- Tbx3 Represses E-Cadherin Expression and Enhances Melanoma Invasiveness
- (2008) M. Rodriguez et al. CANCER RESEARCH
- Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells
- (2008) Kwang-Kyu Kim et al. CARCINOGENESIS
- GSK3β inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes
- (2008) Barbara Bellei et al. CELLULAR SIGNALLING
- Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development
- (2008) M. A. Tran et al. CLINICAL CANCER RESEARCH
- Filamin A Links Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 1 at Lamellipodia To Orchestrate Cell Migration
- (2008) M. Maceyka et al. MOLECULAR AND CELLULAR BIOLOGY
- PBISe, a novel selenium-containing drug for the treatment of malignant melanoma
- (2008) S. V. Madhunapantula et al. MOLECULAR CANCER THERAPEUTICS
- PI3K/Akt: getting it right matters
- (2008) T F Franke ONCOGENE
- Targeting phosphoinositide 3-kinase—Moving towards therapy
- (2007) Romina Marone et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started